Abstract
Pharmaceuticals are becoming widely distributed in waters and wastewaters and pose a serious threat to public health. The present study aimed to analyze non-steroidal anti-inflammatory drugs (NSAIDs) in surface waters, drinking water, and wastewater in Tehran, Iran. Thirty-six samples were collected from surface waters, tap water, and influent and effluent of municipal and hospital wastewater treatment plants (WWTP). A solid-phase extraction (SPE) followed by liquid chromatography–tandem mass spectrometry method was used for the determination of pharmaceuticals, namely ibuprofen (IBP), naproxen (NPX), diclofenac (DIC), and indomethacin (IDM). IBP was found in most of the samples and had the highest concentration. The highest concentrations of NSAIDs were found in the municipal WWTP influents and hospital WWTP effluents. In the municipal WWTP influent samples, the concentrations of IBP, NPX, DIC, and IDM were 1.05, 0.43, 0.23, and 0.11 μg/L, respectively. DIC was found only in one river sample. All NSAIDs were detected in tap water samples. However, their concentration was very low and the maximum values for IBP, NPX, DIC, and IDM were 47, 39, 24, and 37 ng/L, respectively, in tap water samples. Results showed that the measured pharmaceuticals were detected in all rivers with low concentrations in nanograms per liter range, except DIC which was found only in one river. Furthermore, this study showed that the aforementioned pharmaceuticals are not completely removed during their passage through WWTPs. A potential environmental risk of selected NSAIDs for the urban wastewater has been discussed. However, given their low measured concentrations, no ecotoxicological effect is suspected to occur.
Similar content being viewed by others
References
Ali, I., Singh, P., Aboul-Enein, H. Y., & Sharma, B. (2009). Chiral analysis of ibuprofen residues in water and sediment. Analytical Letters, 42(12), 1747–1760. doi:10.1080/00032710903060768.
Andreozzi, R., Raffaele, M., & Nicklas, P. (2003). Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere, 50(10), 1319–1330. doi:10.1016/S0045-6535(02)00769-5.
Barnes, K. K., Kolpin, D. W., Furlong, E. T., Zaugg, S. D., Meyer, M. T., & Barber, L. B. (2008). A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States—I) groundwater. Science of the Total Environment, 402(2–3), 192–200.
Boström, M. L., & Berglund, O. (2015). Influence of pH-dependent aquatic toxicity of ionizable pharmaceuticals on risk assessments over environmental pH ranges. Water Research, 72(0), 154–161. doi:10.1016/j.watres.2014.08.040.
Boyd, G. R., Reemtsma, H., Grimm, D. A., & Mitra, S. (2003). Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Science of the Total Environment, 311(1–3), 135–149. doi:10.1016/S0048-9697(03)00138-4.
Boyd, G. R., Zhang, S., & Grimm, D. A. (2005). Naproxen removal from water by chlorination and biofilm processes. Water Research, 39(4), 668–676. doi:10.1016/j.watres.2004.11.013.
Buser, H.-R., Poiger, T., & Müller, M. D. (1998). Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environmental Science & Technology, 32(22), 3449–3456.
Buser, H.-R., Poiger, T., & Müller, M. D. (1999). Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environmental Science & Technology, 33(15), 2529–2535. doi:10.1021/es981014w.
Camacho-Muñoz, D., Martín, J., Santos, J. L., Aparicio, I., & Alonso, E. (2010). Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain). Journal of Hazardous Materials, 183(1–3), 602–608. doi:10.1016/j.jhazmat.2010.07.067.
Castiglioni, S., Bagnati, R., Fanelli, R., Pomati, F., Calamari, D., & Zuccato, E. (2006). Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science and Technology, 40(1), 357–363.
Chan, C. C., Lam, H., Lee, Y., & Zhang, X.-M. (2004). Analytical method validation and instrument performance verification (vol. 18): Wiley Online Library.
Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., & Kroiss, H. (2005). Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Research, 39(19), 4797–4807. doi:10.1016/j.watres.2005.09.015.
Cleuvers, M. (2004). Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicology and Environmental Safety, 59(3), 309–315.
Daneshvar, A., Svanfelt, J., Kronberg, L., & Weyhenmeyer, G. (2010). Winter accumulation of acidic pharmaceuticals in a Swedish river. Environmental Science and Pollution Research, 17(4), 908–916. doi:10.1007/s11356-009-0261-y.
de Jesus Gaffney, V., Almeida, C. M. M., Rodrigues, A., Ferreira, E., Benoliel, M. J., & Cardoso, V. V. (2015). Occurrence of pharmaceuticals in a water supply system and related human health risk assessment. Water Research, 72, 199–208. doi:10.1016/j.watres.2014.10.027.
EU (2013). Directive 2013/39/EU of the European Parliament and of the Council. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2013:226:0001:0017:EN:PDF (2013).
Fatemi, M. H., & Ghorbannezhad, Z. (2011). Estimation of the volume of distribution of some pharmacologically important compounds from their structural descriptors. Journal of the Serbian Chemical Society, 76(7), 1003–1014.
Fatta, D., Achilleos, A., Nikolaou, A., & Meriç, S. (2007). Analytical methods for tracing pharmaceutical residues in water and wastewater. TrAC Trends in Analytical Chemistry, 26(6), 515–533. doi:10.1016/j.trac.2007.02.001.
Fent, K., Weston, A. A., & Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76(2), 122–159. doi:10.1016/j.aquatox.2005.09.009.
Ferrari, B., Mons, R., Vollat, B., Fraysse, B., Paxēaus, N., Giudice, R. L., et al. (2004). Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environmental Toxicology and Chemistry, 23(5), 1344–1354. doi:10.1897/03-246.
Gentili, A. (2007). Determination of non-steroidal anti-inflammatory drugs in environmental samples by chromatographic and electrophoretic techniques. Analytical and Bioanalytical Chemistry, 387(4), 1185–1202. doi:10.1007/s00216-006-0821-7.
Ginebreda, A., Muñoz, I., de Alda, M. L., Brix, R., López-Doval, J., & Barceló, D. (2010). Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environment International, 36(2), 153–162. doi:10.1016/j.envint.2009.10.003.
Gómez, M. J., Martínez Bueno, M. J., Lacorte, S., Fernández-Alba, A. R., & Agüera, A. (2007). Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere, 66(6), 993–1002. doi:10.1016/j.chemosphere.2006.07.051.
Gros, M., Petrović, M., & Barceló, D. (2007). Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River basin (Northeast Spain). Environmental Toxicology and Chemistry, 26(8), 1553–1562. doi:10.1897/06-495r.1.
Heberer, T., Schmidt-Bäumler, K., & Stan, H. J. (1998). Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: drug residues and other polar contaminants in Berlin surface and groundwater. Acta Hydrochimica et Hydrobiologica, 26(5), 272–278. doi:10.1002/(sici)1521-401x(199809)26:5<272::aid-aheh272>3.0.co;2-o.
Hernando, M. D., Heath, E., Petrovic, M., & Barceló, D. (2006). Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot-survey study. Analytical and Bioanalytical Chemistry, 385(6), 985–991. doi:10.1007/s00216-006-0394-5.
Huerta-Fontela, M., Galceran, M. T., & Ventura, F. (2011). Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Research, 45(3), 1432–1442. doi:10.1016/j.watres.2010.10.036.
Jelic, A., Gros, M., Ginebreda, A., Cespedes-Sánchez, R., Ventura, F., Petrovic, M., et al. (2011). Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Research, 45(3), 1165–1176. doi:10.1016/j.watres.2010.11.010.
Jones, O. A. H., Voulvoulis, N., & Lester, J. N. (2002). Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research, 36(20), 5013–5022. doi:10.1016/S0043-1354(02)00227-0.
Jones, O. A. H., Voulvoulis, N., & Lester, J. N. (2007). The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environmental Pollution, 145(3), 738–744. doi:10.1016/j.envpol.2005.08.077.
Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., & Snyder, S. A. (2007). Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Research, 41(5), 1013–1021.
Kosjek, T., Heath, E., & Kompare, B. (2007). Removal of pharmaceutical residues in a pilot wastewater treatment plant. Analytical and Bioanalytical Chemistry, 387(4), 1379–1387. doi:10.1007/s00216-006-0969-1.
Kreuzinger, N., Clara, M., Strenn, B., & Kroiss, H. (2004). Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Science and Technology, 50, 149–156.
Kulik, N., Trapido, M., Goi, A., Veressinina, Y., & Munter, R. (2008). Combined chemical treatment of pharmaceutical effluents from medical ointment production. Chemosphere, 70(8), 1525–1531. doi:10.1016/j.chemosphere.2007.08.026.
Kumirska, J., Migowska, N., Caban, M., Łukaszewicz, P., & Stepnowski, P. (2015). Simultaneous determination of non-steroidal anti-inflammatory drugs and oestrogenic hormones in environmental solid samples. Science of the Total Environment, 508, 498–505. doi:10.1016/j.scitotenv.2014.12.020.
Limnell, T., Heikkilä, T., Santos, H. A., Sistonen, S., Hellstén, S., Laaksonen, T., et al. (2011). Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles. International Journal of Pharmaceutics, 416(1), 242–251. doi:10.1016/j.ijpharm.2011.06.050.
Lin, A. Y.-C., Yu, T.-H., & Lateef, S. K. (2009). Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. Journal of Hazardous Materials, 167(1–3), 1163–1169. doi:10.1016/j.jhazmat.2009.01.108.
Lindqvist, N., Tuhkanen, T., & Kronberg, L. (2005). Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research, 39(11), 2219–2228. doi:10.1016/j.watres.2005.04.003.
Lolić, A., Paíga, P., Santos, L. H. M. L. M., Ramos, S., Correia, M., & Delerue-Matos, C. (2015). Assessment of non-steroidal anti-inflammatory and analgesic pharmaceuticals in seawaters of north of Portugal: occurrence and environmental risk. Science of the Total Environment, 508, 240–250. doi:10.1016/j.scitotenv.2014.11.097.
Mainero Rocca, L., Gentili, A., Caretti, F., Curini, R., & Pérez-Fernández, V. (2015). Occurrence of non-steroidal anti-inflammatory drugs in surface waters of Central Italy by liquid chromatography–tandem mass spectrometry. International Journal of Environmental Analytical Chemistry, 95(8), 685–697. doi:10.1080/03067319.2015.1046059.
Metcalfe, C. D., Miao, X. S., Koenig, B. G., & Struger, J. (2003). Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environmental Toxicology and Chemistry, 22(12), 2881–2889.
Miao, X.-S., Koenig, B. G., & Metcalfe, C. D. (2002). Analysis of acidic drugs in the effluents of sewage treatment plants using liquid chromatography–electrospray ionization tandem mass spectrometry. Journal of Chromatography A, 952(1–2), 139–147. doi:10.1016/S0021-9673(02)00088-2.
Nikolaou, A., Meric, S., & Fatta, D. (2007). Occurrence patterns of pharmaceuticals in water and wastewater environments. Analytical and Bioanalytical Chemistry, 387(4), 1225–1234. doi:10.1007/s00216-006-1035-8.
Noutsopoulos, C., Koumaki, E., Mamais, D., Nika, M.-C., Bletsou, A. A., & Thomaidis, N. S. (2015). Removal of endocrine disruptors and non-steroidal anti-inflammatory drugs through wastewater chlorination: the effect of pH, total suspended solids and humic acids and identification of degradation by-products. Chemosphere, 119, Supplement(0), S109-S114, doi:10.1016/j.chemosphere.2014.04.107.
Paíga, P., Santos, L. M. L. M., Amorim, C., Araújo, A., Montenegro, M. C. S. M., Pena, A., et al. (2013). Pilot monitoring study of ibuprofen in surface waters of north of Portugal. Environmental Science and Pollution Research, 20(4), 2410–2420. doi:10.1007/s11356-012-1128-1.
Quintana, J. B., & Reemtsma, T. (2004). Sensitive determination of acidic drugs and triclosan in surface and wastewater by ion-pair reverse-phase liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 18(7), 765–774. doi:10.1002/rcm.1403.
Rosal, R., Rodríguez, A., Perdigón-Melón, J. A., Petre, A., García-Calvo, E., Gómez, M. J., et al. (2010). Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Research, 44(2), 578–588. doi:10.1016/j.watres.2009.07.004.
Sanderson, H., Johnson, D. J., Wilson, C. J., Brain, R. A., & Solomon, K. R. (2003). Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicology Letters, 144(3), 383–395. doi:10.1016/S0378-4274(03)00257-1.
Santiago-Morales, J., Agüera, A., Gómez, M. d. M., Fernández-Alba, A. R., Giménez, J., Esplugas, S., et al. (2013). Transformation products and reaction kinetics in simulated solar light photocatalytic degradation of propranolol using Ce-doped TiO2. Applied Catalysis B: Environmental, 129(0), 13–29, doi:10.1016/j.apcatb.2012.09.023.
Scheytt, T., Mersmann, P., Lindstädt, R., & Heberer, T. (2005). 1-octanol/water partition coefficients of 5 pharmaceuticals from human medical care: carbamazepine, clofibric acid, diclofenac, ibuprofen, and propyphenazone. Water, Air, and Soil Pollution, 165(1–4), 3–11. doi:10.1007/s11270-005-3539-9.
Shanmugam, G., Sampath, S., Selvaraj, K., Larsson, D. G. J., & Ramaswamy, B. (2014). Non-steroidal anti-inflammatory drugs in Indian rivers. Environmental Science and Pollution Research, 21(2), 921–931. doi:10.1007/s11356-013-1957-6.
Singh, K. P., Rai, P., Singh, A. K., Verma, P., & Gupta, S. (2014). Occurrence of pharmaceuticals in urban wastewater of north Indian cities and risk assessment. Environmental Monitoring and Assessment, 186(10), 6663–6682.
Suzuki, T., Kosugi, Y., Hosaka, M., Nishimura, T., & Nakae, D. (2014). Occurrence and behavior of the chiral anti-inflammatory drug naproxen in an aquatic environment. Environmental Toxicology and Chemistry, n/a-n/a. doi:10.1002/etc.2741.
Tixier, C., Singer, H. P., Oellers, S., & Müller, S. R. (2003). Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environmental Science and Technology, 37(6), 1061–1068. doi:10.1021/es025834r.
Togunde, O. P., Oakes, K. D., Servos, M. R., & Pawliszyn, J. (2012). Determination of pharmaceutical residues in fish bile by solid-phase microextraction couple with liquid chromatography-tandem mass spectrometry (LC/MS/MS). Environmental Science & Technology, 46(10), 5302–5309. doi:10.1021/es203758n.
Tran, N. H., Urase, T., & Ta, T. T. (2014). A preliminary study on the occurrence of pharmaceutically active compounds in hospital wastewater and surface water in Hanoi, Vietnam. CLEAN – Soil, Air, Water, 42(3), 267–275. doi:10.1002/clen.201300021.
USEPA (2007). Pharmaceuticals and personal care products in water, soil, sediment, and biosolids by HPLC/MS/MS. U.S. Environmental Protection Agency Office of Water Office of Science and Technology Engineering and Analysis Division. (pp. 77). Washington, DC 20460.
Vane, J. R., & Botting, R. M. (1998). Anti-inflammatory drugs and their mechanism of action. Inflammation Research, 47(2), 78–87. doi:10.1007/s000110050284.
Vieno, N., & Sillanpää, M. (2014). Fate of diclofenac in municipal wastewater treatment plant—a review. Environment International, 69(0), 28–39. doi:10.1016/j.envint.2014.03.021.
Weigel, S., Berger, U., Jensen, E., Kallenborn, R., Thoresen, H., & Hühnerfuss, H. (2004). Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere, 56(6), 583–592. doi:10.1016/j.chemosphere.2004.04.015.
Yamamoto, H., Nakamura, Y., Kitani, C., Imari, T., Sekizawa, J., Takao, Y., et al. (2007). Initial ecological risk assessment of eight selected human pharmaceuticals in Japan. Environmental Sciences : an International Journal of Environmental Physiology and Toxicology, 14(4), 177–193.
Ziylan, A., & Ince, N. H. (2011). The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. Journal of Hazardous Materials, 187(1–3), 24–36. doi:10.1016/j.jhazmat.2011.01.057.
Zorita, S., Mårtensson, L., & Mathiasson, L. (2009). Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Science of the Total Environment, 407(8), 2760–2770. doi:10.1016/j.scitotenv.2008.12.030.
Zwiener, C., & Frimmel, F. H. (2000). Oxidative treatment of pharmaceuticals in water. Water Research, 34(6), 1881–1885. doi:10.1016/S0043-1354(99)00338-3.
Acknowledgments
This work was supported by a grant (No. 92-03-46-24061) from Tehran University of Medical Sciences Center of the Air Pollution Research (CAPR). This work was undertaken as a part of the PhD dissertation at the School of Public Health, Shahid Beheshti University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eslami, A., Amini, M.M., Yazdanbakhsh, A.R. et al. Occurrence of non-steroidal anti-inflammatory drugs in Tehran source water, municipal and hospital wastewaters, and their ecotoxicological risk assessment. Environ Monit Assess 187, 734 (2015). https://doi.org/10.1007/s10661-015-4952-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10661-015-4952-1